These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 24598210

  • 1. Azilsartan improves glycemic status and reduces kidney damage in zucker diabetic fatty rats.
    Hye Khan MA, Neckář J, Haines J, Imig JD.
    Am J Hypertens; 2014 Aug; 27(8):1087-95. PubMed ID: 24598210
    [Abstract] [Full Text] [Related]

  • 2. Azilsartan decreases renal and cardiovascular injury in the spontaneously hypertensive obese rat.
    Hye Khan MA, Neckář J, Cummens B, Wahl GM, Imig JD.
    Cardiovasc Drugs Ther; 2014 Aug; 28(4):313-22. PubMed ID: 24842561
    [Abstract] [Full Text] [Related]

  • 3. A dual COX-2/sEH inhibitor improves the metabolic profile and reduces kidney injury in Zucker diabetic fatty rat.
    Hye Khan MA, Hwang SH, Sharma A, Corbett JA, Hammock BD, Imig JD.
    Prostaglandins Other Lipid Mediat; 2016 Sep; 125():40-7. PubMed ID: 27432695
    [Abstract] [Full Text] [Related]

  • 4. Prevention of diabetic nephropathy by compound 21, selective agonist of angiotensin type 2 receptors, in Zucker diabetic fatty rats.
    Castoldi G, di Gioia CR, Bombardi C, Maestroni S, Carletti R, Steckelings UM, Dahlöf B, Unger T, Zerbini G, Stella A.
    Am J Physiol Renal Physiol; 2014 Nov 15; 307(10):F1123-31. PubMed ID: 25186297
    [Abstract] [Full Text] [Related]

  • 5. Chronic NF-κB blockade improves renal angiotensin II type 1 receptor functions and reduces blood pressure in Zucker diabetic rats.
    Luo H, Wang X, Wang J, Chen C, Wang N, Xu Z, Chen S, Zeng C.
    Cardiovasc Diabetol; 2015 Jun 10; 14():76. PubMed ID: 26055622
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Azilsartan ameliorates diabetic cardiomyopathy in young db/db mice through the modulation of ACE-2/ANG 1-7/Mas receptor cascade.
    Sukumaran V, Tsuchimochi H, Tatsumi E, Shirai M, Pearson JT.
    Biochem Pharmacol; 2017 Nov 15; 144():90-99. PubMed ID: 28789938
    [Abstract] [Full Text] [Related]

  • 9. Long-term treatment with nebivolol attenuates renal damage in Zucker diabetic fatty rats.
    Toblli JE, Cao G, Giani JF, Muñoz MC, Angerosa M, Dominici FP.
    J Hypertens; 2011 Aug 15; 29(8):1613-23. PubMed ID: 21720265
    [Abstract] [Full Text] [Related]

  • 10. Single-Center Evaluation of the Pharmacokinetics and Safety of the Angiotensin II Receptor Antagonist Azilsartan Medoxomil in Mild to Moderate Hepatic Impairment.
    Dudkowski C, Karim A, Zhao Z, Alonso AB, Garg D, Preston RA.
    J Clin Pharmacol; 2018 Jan 15; 58(1):48-56. PubMed ID: 28750149
    [Abstract] [Full Text] [Related]

  • 11. The angiotensin-II (AT-II) receptor blocker olmesartan reduces renal damage in animal models of hypertension and diabetes.
    Pugsley MK.
    Proc West Pharmacol Soc; 2005 Jan 15; 48():35-8. PubMed ID: 16416656
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antihypertensive, insulin-sensitising and renoprotective effects of a novel, potent and long-acting angiotensin II type 1 receptor blocker, azilsartan medoxomil, in rat and dog models.
    Kusumoto K, Igata H, Ojima M, Tsuboi A, Imanishi M, Yamaguchi F, Sakamoto H, Kuroita T, Kawaguchi N, Nishigaki N, Nagaya H.
    Eur J Pharmacol; 2011 Nov 01; 669(1-3):84-93. PubMed ID: 21816148
    [Abstract] [Full Text] [Related]

  • 15. Increased aldosterone levels in a model of type 2 diabetes mellitus.
    Fredersdorf S, Endemann DH, Luchner A, Heitzmann D, Ulucan C, Birner C, Schmid P, Stoelcker B, Resch M, Muders F, Riegger GA, Weil J.
    Exp Clin Endocrinol Diabetes; 2009 Jan 01; 117(1):15-20. PubMed ID: 18726873
    [Abstract] [Full Text] [Related]

  • 16. Renoprotective effects of blockade of angiotensin II AT1 receptors in an animal model of type 2 diabetes.
    Mizuno M, Sada T, Kato M, Koike H.
    Hypertens Res; 2002 Mar 01; 25(2):271-8. PubMed ID: 12047043
    [Abstract] [Full Text] [Related]

  • 17. Chronic Running Exercise Alleviates Early Progression of Nephropathy with Upregulation of Nitric Oxide Synthases and Suppression of Glycation in Zucker Diabetic Rats.
    Ito D, Cao P, Kakihana T, Sato E, Suda C, Muroya Y, Ogawa Y, Hu G, Ishii T, Ito O, Kohzuki M, Kiyomoto H.
    PLoS One; 2015 Mar 01; 10(9):e0138037. PubMed ID: 26379244
    [Abstract] [Full Text] [Related]

  • 18. Antihypertensive efficacy of hydrochlorothiazide vs chlorthalidone combined with azilsartan medoxomil.
    Bakris GL, Sica D, White WB, Cushman WC, Weber MA, Handley A, Song E, Kupfer S.
    Am J Med; 2012 Dec 01; 125(12):1229.e1-1229.e10. PubMed ID: 22939358
    [Abstract] [Full Text] [Related]

  • 19. The effect of angiotensin II receptor blockade on an end-stage renal failure model of type 2 diabetes.
    Mizuno M, Sada T, Kato M, Fukushima Y, Terashima H, Koike H.
    J Cardiovasc Pharmacol; 2006 Oct 01; 48(4):135-42. PubMed ID: 17086090
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.